Hookipa Pharma Inc Revenue Growth Rates (HOOK), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Hookipa Pharma inc   (NASDAQ: HOOK)
 

HOOK's Revenue Growth by Quarter and Year

Hookipa Pharma Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HOOK Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 2.00
FY 2.00

HOOKs Annual Revenue
Hookipa Pharma Inc 's Revenue in the fiscal year 2024 $ 43.95 millions
Hookipa Pharma Inc 's Revenue in the fiscal year 2023 $ 20.13 millions
Hookipa Pharma Inc 's Revenue in the fiscal year 2022 $ 14.25 millions
Hookipa Pharma Inc 's Revenue in the fiscal year 2021 $ 18.45 millions
Hookipa Pharma Inc 's Revenue in the fiscal year 2020 $ 19.58 millions




HOOK Revenue first quarter 2025 Y/Y Growth Comment
Hookipa Pharma Inc reported drop in Revenue in the first quarter 2025 by -94.52% to $ 2.00 millions, from the same quarter in 2024.
The fall in the first quarter 2025 Hookipa Pharma Inc 's Revenue compares unfavorably to the Company's average Revenue jump of 54.89%.

Looking into first quarter 2025 results within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Revenue growth. While Hookipa Pharma Inc ' s Revenue meltdown of -94.52% ranks overall at the positon no. 51 in the first quarter 2025.


HOOK Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - -81.78 % -5.36 % 101.29 %
3rd Quarter September - -31.59 % 208.07 % -42.38 %
2nd Quarter June - -51.87 % -2.55 % -48.88 %
1st Quarter March -94.52 % 1050.94 % 119.31 % -72.64 %
FY   - 118.17 % 41.23 % -

Financial Statements
Hookipa Pharma Inc 's first quarter 2025 Revenue $ 2.00 millions HOOK's Income Statement
Hookipa Pharma Inc 's first quarter 2024 Revenue $ 36.60 millions Quarterly HOOK's Income Statement


HOOK Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - -71.28 % 7.86 % 251.12 %
3rd Quarter September - 264.34 % 156.34 % -18.91 %
2nd Quarter June - -96.48 % -15.72 % 89.66 %
1st Quarter March 48.44 % 393.93 % -59.39 % -62.72 %
FY (Year on Year)   - 118.17 % 41.23 % -


Back to HOOK Growth rate Comparisons >> Back to HOOK Growth rate Comparisons >>


Revenue first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #19
Overall #51

Revenue Y/Y Growth Statistics
High Average Low
235.12 % 54.89 % -82.54 %
(Mar 31 2024)   (Mar 31 2025)
Revenue first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #19
Overall #51
Revenue Y/Y Growth Statistics
High Average Low
235.12 % 54.89 % -82.54 %
(Mar 31 2024)   (Mar 31 2025)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Hookipa Pharma Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
394.11 % 50.76 % -96.48 %
(Mar 31 2024)  


HOOK's I. Quarter Q/Q Revenue Comment
Hookipa Pharma inc achieved in the I. Quarter 2025 below company average Revenue jump of 48.44% quarter on quarter, to $ 2.00 millions.

Within Major Pharmaceutical Preparations industry 33 other companies have achieved higher Revenue quarter on quarter growth. While Hookipa Pharma Inc 's Revenue growth quarter on quarter, overall rank is 283.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #34
Healthcare Sector #66
Overall #283
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #34
Healthcare Sector #66
Overall #283
Revenue Q/Q Growth Statistics
High Average Low
394.11 % 50.76 % -96.48 %
(Mar 31 2024)  


HOOK's I. Quarter Q/Q Revenue Comment
Hookipa Pharma inc achieved in the I. Quarter 2025 below company average Revenue jump of 48.44% quarter on quarter, to $ 2.00 millions.

Within Major Pharmaceutical Preparations industry 33 other companies have achieved higher Revenue quarter on quarter growth. While Hookipa Pharma Inc 's Revenue growth quarter on quarter, overall rank is 283.


Hookipa Pharma Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)
Cumulative Revenue 12 Months Ending $ 9.35 $ 43.95 $ 50.00 $ 52.16 $ 53.55
Y / Y Revenue Growth (TTM) -82.54 % 118.32 % 143.3 % 227.8 % 235.12 %
Year on Year Revenue Growth Overall Ranking # 50 # 120 # 92 # 338 # 1335
Seqeuential Revenue Change (TTM) -78.72 % -12.11 % -4.15 % -2.59 % 166.04 %
Seq. Revenue Growth (TTM) Overall Ranking # 67 # 1554 # 315 # 1247 # 815


Cumulative Revenue growth Comment
For the 12 months ended Mar 31 2025 Hookipa Pharma Inc reported a sharp drop in Revenue by -82.54% year on year, to $9 millions, compare to the 118.32% growth at Dec 31 2024.

Among companies within the Healthcare sector 16 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 50, from total ranking in previous quarter at 120.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 12
Healthcare Sector # 17
Overall # 50

Revenue TTM Y/Y Growth Statistics
High Average Low
235.12 %
 54.89 %
-82.54 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 24
S&P 500 # 67
Cumulative Revenue growth Comment
For the 12 months ended Mar 31 2025 Hookipa Pharma Inc reported a sharp drop in Revenue by -82.54% year on year, to $9 millions, compare to the 118.32% growth at Dec 31 2024.

Among companies within the Healthcare sector 16 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 50, from total ranking in previous quarter at 120.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 12
Healthcare Sector # 17
Overall # 50

Revenue TTM Y/Y Growth Statistics
High Average Low
235.12 %
54.89 %
-82.54 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 24
S&P 500 # 67




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
HOOK's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue sharp drop for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2025
Carlisle Companies Incorporated-0.06%$ -0.064 millions
Henry Schein Inc -0.13%$ -0.126 millions
Tactile Systems Technology Inc -0.14%$ -0.137 millions
Alpha Pro Tech Ltd -0.19%$ -0.186 millions
Premier Air Charter Holdings Inc -0.20%$ -0.204 millions
Gilead Sciences Inc -0.28%$ -0.284 millions
Adm Tronics Unlimited Inc -0.32%$ -0.315 millions
Jazz Pharmaceuticals Plc-0.46%$ -0.459 millions
Milestone Scientific Inc -0.73%$ -0.730 millions
Logicmark Inc-0.74%$ -0.738 millions
Yunhong Green Cti Ltd -0.74%$ -0.745 millions
Amphastar Pharmaceuticals Inc -0.76%$ -0.761 millions
Enhabit Inc -0.95%$ -0.953 millions
Elanco Animal Health Incorporated-1.00%$ -0.996 millions
3m Company-1.03%$ -1.031 millions
Envista Holdings Corporation-1.17%$ -1.171 millions
Globus Medical Inc -1.41%$ -1.409 millions
Proqr Therapeutics N v -1.53%$ -1.528 millions
Merck and Co Inc -1.56%$ -1.559 millions
Icad Inc-1.61%$ -1.615 millions
Fortrea Holdings Inc -1.63%$ -1.631 millions
Align Technology inc -1.78%$ -1.776 millions
Adapthealth Corp -1.84%$ -1.844 millions
Sunlink Health Systems Inc -2.05%$ -2.050 millions
Tonix Pharmaceuticals Holding Corp -2.14%$ -2.135 millions
Alpha Teknova Inc -2.19%$ -2.194 millions
Quidelortho Corp-2.56%$ -2.560 millions
Teladoc Health Inc -2.59%$ -2.594 millions
Tenet Healthcare Corp-2.70%$ -2.701 millions
Charles River Laboratories International inc -2.71%$ -2.708 millions


About Hookipa Pharma Inc Revenue Growth Rates (HOOK), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Hookipa Pharma Inc (CIK 1760542).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001558370-25-007871
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Hookipa Pharma Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.